Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Continuous evolution of compact protein degradation tags regulated by selective molecular glues
Jaron A. M. Mercer, Stephan J. DeCarlo, Shourya S. Roy Burman, et al.
Science (2024) Vol. 383, Iss. 6688
Open Access | Times Cited: 22

Showing 22 citing articles:

Small molecule-mediated targeted protein degradation of voltage-gated sodium channels involved in pain
Alexander Chamessian, Maria A. Payne, Isabelle R. Gordon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
The emerging role of targeted protein degradation to treat and study cancer
Maximillian H. Brodermann, Elizabeth Henderson, Rob S. Sellar
The Journal of Pathology (2024) Vol. 263, Iss. 4-5, pp. 403-417
Open Access | Times Cited: 5
Degradation bottlenecks and resource competition in transiently and stably engineered mammalian cells
Jacopo Gabrielli, Roberto Di Blasi, Cleo Kontoravdi, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Differential Protein Degradation with a Super-Degron Tag and Thalidomide Analogs: EGFP is Degraded in Wild-Type Mouse Cell, While PD-1 Requires CRBN Humanization, Providing New Insights into T Cell Regulation
Chie Naruse, Osamu Ishibashi, Masatoshi Ohgushi, et al.
(2025)
Closed Access
Systematic evolution of functional oligonucleotides for targeted protein degradation
Huang Su, Yifan Chen, Xuyang Zhao, et al.
Chem (2025), pp. 102408-102408
Closed Access
E3 ubiquitin ligases and their therapeutic potential in disease Management
Geet Madhukar, Md Azizul Haque, Shawez Khan, et al.
Biochemical Pharmacology (2025), pp. 116875-116875
Closed Access
Multilayered HIV-1 resistance in HSPCs through CCR5 Knockout and B cell secretion of HIV-inhibiting antibodies
William N. Feist, Sofia E. Luna, Kaya Ben-Efraim, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Degron tagging for rapid protein degradation in mice
Brianda Areli Hernández-Morán, Gillian C.A. Taylor, Álvaro Lorente‐Macías, et al.
Disease Models & Mechanisms (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 4
Identification of actionable targeted protein degradation effector sites through Site-specific Ligand Incorporation-induced Proximity (SLIP)
Zhangping Xiao, Efthymios Spyridon Gavriil, Fangyuan Cao, et al.
(2025)
Open Access
Mining the CRBN Target Space Redefines Rules for Molecular Glue-induced Neosubstrate Recognition
Georg Petzold, Pablo Gaínza, Stefano Annunziato, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Degradation Bottlenecks and Resource Competition in Transiently and Stably Engineered Mammalian Cells
Jacopo Gabrielli, Roberto Di Blasi, Cleo Kontoravdi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Lessons from natural molecular glue degraders
Shiyun Cao
Biochemical Society Transactions (2024) Vol. 52, Iss. 3, pp. 1191-1197
Closed Access | Times Cited: 1
CRBN‐PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications
Riya Thapa, Asif Ahmad Bhat, Gaurav Gupta, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 5
Open Access | Times Cited: 1
Crispr-based gene therapy for the induction of fetal hemoglobin in sickle cell disease
Meghann McManus, Haydar Frangoul, Martin H. Steinberg
Expert Review of Hematology (2024)
Closed Access | Times Cited: 1
Combination of AID2 and BromoTag expands the utility of degron-based protein knockdowns
Yuki Hatoyama, Moutushi Islam, Adam G. Bond, et al.
EMBO Reports (2024) Vol. 25, Iss. 9, pp. 4062-4077
Closed Access
Protein degradation by small tag artificial bacterial E3 ligase
Zhenyi Liu, Ming‐Chi Tsai, Soumitra Ghosh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
High-throughput optimized prime editing mediated endogenous protein tagging for pooled imaging of protein localization
Henry M. Sanchez, Tomer Lapidot, Ophir Shalem
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Degron-modified Cas12a enhances single-cell CRISPR screening
Valentina Snetkova, Carolina Galan, Romain Lopez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
GPCR-targeted PROTACs in Cancer Therapeutics
Victoria R. Saca, Thomas Huber, Thomas P. Sakmar
Molecular Pharmacology (2024) Vol. 107, Iss. 2, pp. 100013-100013
Open Access
Targeted KRASG12Vdegradation elicits efficient and durable lung adenocarcinoma regressionin vivo
Alberto J. M. Martín, Inmaculada García-Peréz, Sonia San José, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Chemically-inducible CRISPR/Cas9 circuits for ultra-high dynamic range gene perturbation
Rajini Srinivasan, Tao Sun, Azalia Sandles, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top